Eight-Time All-Star Chris Paul and GlassesOff Partner to Develop Innovative Mobile App Designed …

NEW YORK, August 27, 2015 /PRNewswire/ —

GlassesOff (OTCBB: GLSO), a visual neuroscience technology company focusing on enhancing image processing functions in the human vision system, announced today a partnership with eight-time All-Star, Los Angeles point guard Chris Paul to develop a new mobile app designed for professional and recreational basketball players who want to improve their real-life on-court performance.

Vision is the inception of every move made on the court, whether it is shooting a ball or blocking a pass. The critical impact vision speed has on sports performance led to the development of this innovative platform technology, which is intended to serve as a powerful tool in players’ training routines, on their way to realizing their full potential.

Chris Paul said: “As a professional athlete, I know that vision speed is just as essential for on-court performance as running fast or jumping high. I’m proud and excited to be a part of this groundbreaking app that can potentially help players of all ages and all levels reach their potential.”

Nimrod Madar, CEO of GlassesOff said: “We are delighted to partner up with a world-class sports icon for this pioneering project, aiming at helping young basketball players improve their sports performance. I feel Chris, being a leader and a role model, is the perfect partner to bring this new innovative technology to market.”

About Chris Paul: 

Chris Paul is an American professional basketball player. The face of his Los Angeles franchise, on the court, he’s a force to be reckoned with and a fierce competitor.  A two-time gold medalist and eight-time All-Star, Paul is also a perennial leader in the assists and steals category and one of the most heralded point guards in the game. Off the court, he’s a father, a husband, and a compassionate philanthropist. Paul, or CP3, as fans affectionately call him, is building a robust brand and making a huge difference in his community, all while creating a powerful legacy.

About GlassesOff: 

GlassesOff Inc. (OTCBB:GLSO) is a public, a visual neuroscience technology company, utilizing patented technology to develop and commercialize consumer-oriented software applications. The Company is developing and commercializing next generation vision performance applications. GlassesOff has developed a proprietary, patent protected neuroscience technology platform to improve vision performance through brain exercise, by improving the image processing function in the visual cortex of the brain. http://www.glassesoff.com

Safe Harbor Statement: This press release contains forward-looking statements, which may be identified by words such as “expects,” “plans,” “projects,” “will,” “may,” “anticipates,” “believes,” “should,” “would,” “intends,” “estimates,” “suggests,” “has the potential to,” “aims” and other words and phrases of similar meaning, including statements regarding the results of effectiveness of GLASSESOFF’s applications. Investors are cautioned that forward-looking statements involve risks and uncertainties that may affect GLASSESOFF’s business and prospects, including the risks that GLASSESOFF may not succeed in generating any revenues or developing any commercial products, that the products may not achieve the expected results or effectiveness, and other risks and uncertainties that may cause results to differ materially from those set forth in the forward-looking statements. In addition to the risk factors described above, investors should consider the economic, competitive, governmental, technological and other factors discussed in GLASSESOFF’s filings with the Securities and Exchange Commission. The forward-looking statements contained in this press release speak only as of the date the statements were made, and we do not undertake any obligation to update forward-looking statements, except as required under applicable law.

Source: Eight-Time All-Star Chris Paul and GlassesOff Partner to Develop Innovative Mobile App Designed …

Via: Google Alert for Neuroscience